<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-5 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-5</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-5</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <p><strong>Paper ID:</strong> paper-248164281</p>
                <p><strong>Paper Title:</strong> Genomic profiling reveals non-small cell lung cancer with common mutations of EGFR exon 20 and exon 21: a case report</p>
                <p><strong>Paper Abstract:</strong> Background Epidermal growth factor receptor (EGFR) gene is one of the most common driver genes for non-small cell lung cancer (NSCLC). The PIONEER study showed that 51.4% of unselected Asian patients with advanced lung adenocarcinoma have EGFR-sensitive mutations. EGFR mutations mainly occur in the first four [18â€“21] exons of the intracellular tyrosine kinase (TK) region. At present, there are more than 30 types of mutations in the TK region, including exon 19 deletion mutation (19Del) and exon 21 L858R mutation (L858R) which are the most common types of sensitive mutations, accounting for more than 90% of all EGFR mutations. About 10% of NSCLC patients with EGFR mutations are rare mutation types, including exon 18 point mutation (G719X), exon 20 point mutation (S768I), exon 19 point mutation (L747S), exon 21 point mutation (L833V), etc. About 1% of NSCLC patients have primary double mutations of EGFR. Case Description In this present study, we identified a 59-year-old female patient with no smoking history had double mutations in EGFR exon 20 R776S mutation and exon 21 L858R mutation by next-generation sequencing (NGS). Conclusions This observation may explore a new mechanism study for EGFR-TKIs and provide a new direction for clinical treatment of NSCLC.</p>
                <p><strong>Cost:</strong> 0.01</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e5.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e5.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PIONEER</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A prospective molecular epidemiology study referenced in this paper reporting the prevalence of EGFR-sensitive mutations in an unselected Asian cohort with advanced lung adenocarcinoma (reported prevalence 51.4%).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Unselected Asian patients with advanced lung adenocarcinoma (PIONEER cohort); sample size not specified in this paper</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Asian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>51.4% (EGFR-sensitive mutations reported in unselected Asian patients with advanced lung adenocarcinoma, as cited from PIONEER)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Advanced lung adenocarcinoma (study focused on adenocarcinoma histology)</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Asia (broadly described as Asian patients; no within-Asia geographic breakdown given in this paper)</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e5.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e5.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_common_mutation_distribution</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Distribution of common EGFR tyrosine kinase domain mutations in NSCLC (exons 18-21)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Summary reported in this paper that the vast majority of sensitizing EGFR mutations are exon 19 deletions and exon 21 L858R (>90% of EGFR mutations), with ~10% being rare mutation types and ~1% primary double mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>General NSCLC patient population (not a single cohort described in this paper; stated as general epidemiologic summary)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>>90% of EGFR mutations are exon 19 deletions and exon 21 L858R; ~10% are rare mutation types; ~1% have primary double EGFR mutations</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Exon 19 deletion (19Del) and exon 21 L858R are most common (>90%); rare mutations include exon 18 (G719X), exon 20 (S768I), exon 19 point mutations (L747S), exon 21 point mutations (L833V), etc.; primary double mutations ~1%</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>NSCLC (EGFR-mutated tumors are typically adenocarcinomas in clinical practice)</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e5.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e5.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_never_smoker_association</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib.</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A cited finding (Pao et al., 2004) noted in the paper that EGFR mutations are common among lung cancers arising in never-smokers, establishing an association between EGFR mutation status and smoking history.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Not specified in detail in this paper (cited reference studied lung cancer patients stratified by smoking history)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td>Association highlighted: EGFR mutations are common in tumors from never-smokers (statement cited from prior work)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>EGFR mutations reported to be more common in never-smokers (cited observation); no quantitative comparison provided in this paper</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Implicit comparison between never-smokers and smokers (no numbers provided in this paper)</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>EGFR-mutant tumors showing sensitivity to EGFR-TKIs (gefitinib, erlotinib)</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e5.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e5.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>This_case_China_R776S_L858R</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Genomic profiling reveals non-small cell lung cancer with common mutations of EGFR exon 20 and exon 21: a case report</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Single-case report of a 59-year-old Chinese female never-smoker with stage IA lung adenocarcinoma harboring co-occurring EGFR exon 21 L858R (MAF 6.3%) and exon 20 R776S (MAF 4.7%) detected by NGS and confirmed by RNA-seq.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Single patient: 59-year-old Chinese female, never-smoker, stage IA (T1cN0M0) lung adenocarcinoma, treated surgically in Dalian, China</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Chinese (East Asian)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Mutant allele frequencies reported in tumor tissue: L858R MAF 6.3%, R776S MAF 4.7% (single-case values)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>EGFR exon 21 c.2573T>G (p.L858R); EGFR exon 20 c.2326C>A (p.R776S)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td>Never-smoker (patient)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>Single-case observation: EGFR double mutations present in a never-smoker (no population-level association claimed in this paper)</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors suggest that this unusual exon 20/exon 21 double mutation might offer insight into mechanisms of EGFR-TKI sensitivity/resistance, but no population-level mechanistic explanation for ethnic differences is proposed</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Moderately differentiated adenocarcinoma (80% acinar, 20% mural), stage IA; tumor mutational burden 2.3 mut/Mb; no other somatic mutations detected</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Patient located in Dalian, Liaoning, China (no broader geographic comparisons made)</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) <em>(Rating: 2)</em></li>
                <li>Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib <em>(Rating: 1)</em></li>
                <li>EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. <em>(Rating: 2)</em></li>
                <li>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. <em>(Rating: 1)</em></li>
                <li>Epidermal growth factor receptor mutations in lung cancer. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>